Where to Go in China for a Healthy Baby with Genetic Disorders: A Guide to PGT Hospitals

Opening: Real consultation scenario

Reproductive Genetics Clinic · Real Consultation Scenario

"Doctor, I have a genetic disorder. Can I have a healthy baby? Where in China should I go?" This is one of the most frequently asked questions in reproductive genetics clinics. Among those asking are patients with a clear family history of single-gene disorders, couples who have experienced recurrent miscarriages due to balanced chromosomal translocations, and healthy individuals worried about carrying recessive pathogenic genes. The expression on every consultant's face carries a similar mix of anxiety and hope — they need not just a "yes" or "no" answer, but a clear, actionable path.

I. Want a Healthy Baby with a Genetic Disorder: Direct Answer

The answer is: Go to a reproductive center in China with PGT (Preimplantation Genetic Testing) qualifications. PGT technology, often called "third-generation IVF," allows for genetic testing of embryos before transfer, selecting embryos that do not carry the pathogenic gene or have normal chromosomes for transfer, thereby blocking the intergenerational transmission of genetic diseases.

China currently has over 70 medical institutions approved by the National Health Commission to perform PGT technology (as of the latest published data), distributed across various provinces and cities. Below are some representative centers (in no particular order):

Choosing which hospital depends on the type of genetic disorder, the hospital's technical specialties, geographical convenience, and the quality control level of the laboratory. Not all PGT centers excel in all types of genetic disease testing; some centers have more experience in single-gene disorder testing, while others specialize in chromosomal structural abnormalities.

II. How Doctors View "Having a Healthy Baby with a Genetic Disorder"

From the perspective of a reproductive genetics doctor, evaluating whether a family with a history of genetic disorders can have a healthy baby through PGT requires answering three core questions:

• Is the pathogenic gene identified? Only when the pathogenic gene (or chromosomal abnormality segment) is clearly identified does PGT testing have a target. If the genetic diagnosis is unclear, PGT cannot proceed.
• Is the inheritance pattern suitable for PGT blockade? Autosomal dominant, recessive, X-linked, and chromosomal structural abnormalities all have corresponding PGT strategies. However, some polygenic disorders (e.g., diabetes, hypertension) currently cannot be effectively blocked by PGT.
• Does the patient's ovarian function and fertility status support an IVF cycle? PGT requires multiple steps including ovarian stimulation, egg retrieval, in vitro fertilization, embryo culture, biopsy, testing, and frozen-thawed transfer. The woman's age and ovarian reserve directly affect the number of available embryos.

III. The Actual Process of PGT for Blocking Genetic Disorders

From initial consultation to transfer, a complete PGT cycle typically takes 3 to 6 months, depending on the type of genetic disorder, testing protocol, and the patient's physical condition. Below is the standardized process:

1. Genetic Counseling and Genetic Diagnosis (1-2 months) — Confirm the pathogenic gene, complete family verification (blood tests from parents or proband samples may be needed), and obtain a clear testing target.
2. Develop IVF+PGT Protocol — The reproductive doctor formulates an ovarian stimulation protocol based on the woman's age, AMH, antral follicle count, and hormone levels. Meanwhile, the embryology lab determines the biopsy method and testing platform.
3. Ovarian Stimulation and Egg Retrieval (about 2 weeks) — Standard IVF procedure aimed at obtaining a sufficient number of eggs.
4. Fertilization and Embryo Culture (5-6 days) — ICSI fertilization is used, and embryos are cultured to the blastocyst stage (day 5-6), at which point the embryo has about 100-200 cells.
5. Embryo Biopsy — 3-5 cells are removed from the trophectoderm of the blastocyst for testing. The biopsy is performed by a senior embryologist.
6. Genetic Testing (2-4 weeks) — Testing methods are chosen based on the type of genetic disorder: PGT-A (chromosomal number screening), PGT-M (single-gene disorder testing), PGT-SR (chromosomal structural rearrangement testing), or a combination.
7. Assessment of Transferable Embryos — The geneticist issues a test report determining which embryos do not carry the pathogenic gene and have normal chromosomes.
8. Frozen-Thawed Transfer — 1-2 normal embryos are selected for frozen-thawed transfer, usually in the next cycle or a specific window period.
9. Post-Transfer Follow-up and Prenatal Diagnosis — Pregnancy test 12-14 days after transfer. If pregnancy is confirmed, amniocentesis in the second trimester is recommended for verification to rule out testing errors.

IV. Interpretation of Key Examination Indicators

In the PGT process, several core indicators directly influence protocol selection and success rates:

V. Most Easily Overlooked Details

In clinical practice, the following details are often overlooked by patients but are crucial for PGT success:

• Family verification needs to be completed in advance — Many patients think only their own blood sample is needed. However, PGT-M often requires blood samples from parents or the proband to construct haplotypes; otherwise, testing accuracy decreases. Family verification should be completed before starting the IVF cycle.
• Not all genetic disorders can be completely blocked by PGT — For some genetic disorders (e.g., mitochondrial diseases, some polygenic disorders), PGT has limited effectiveness and may need to be combined with prenatal diagnosis or even third-generation sequencing.
• The choice of testing platform affects waiting time — Different centers have different testing platforms and cycle schedules. The time from biopsy to report can range from 2 to 4 weeks. Some centers send samples in batches, which may increase waiting time.
• Embryo biopsy carries a certain risk of loss — Although biopsy has a minor impact on blastocysts, a small number of embryos may have reduced survival rates or stop developing after biopsy. Therefore, a margin should be allowed when planning the protocol.
• Genetic counseling is not a one-time event — After successful PGT, genetic follow-up is still recommended for the baby after birth, as some genetic disorders may involve new mutations or mosaicism.

VI. Common Types of Genetic Disorders and PGT Strategies

The applicability and protocols of PGT vary significantly depending on the type of genetic disorder. Below are three typical scenarios:

VII. Frequently Asked Questions

7.1 Can PGT technology guarantee 100% a healthy baby?

No. PGT technology can reduce the risk of transmitting genetic disorders to less than 1% to 3%, but it cannot completely eliminate it. Reasons include limitations of testing technology (e.g., mosaicism, new mutations), sampling errors during embryo biopsy, and incomplete penetrance of some genetic disorders. Therefore, prenatal diagnosis (amniocentesis or chorionic villus sampling) is recommended for all PGT pregnancies for verification.

7.2 Can someone with a genetic disorder but advanced age (>38 years old) still undergo PGT?

Yes, but ovarian reserve needs to be fully assessed. Older women may have fewer eggs retrieved and a lower proportion of available embryos. The doctor will evaluate indicators such as AMH, FSH, and AFC to determine the feasibility and cost-effectiveness of PGT. Some patients may need multiple ovarian stimulation cycles to accumulate embryos before PGT testing.

7.3 What is the approximate cost of PGT for genetic disorders?

In China, the cost of PGT varies depending on the hospital, type of testing, and number of embryos. The total cost per cycle (including IVF + PGT testing) is typically between 50,000 and 100,000 RMB. PGT-M and PGT-SR are usually more expensive than PGT-A due to higher testing complexity. Some tests are charged per embryo, with additional costs beyond a certain number.

7.4 What if there are no normal embryos after PGT?

This is the most regrettable outcome of a PGT cycle. Possible reasons include: poor ovarian function leading to few available embryos, or the type of genetic disorder resulting in a low proportion of normal embryos (e.g., balanced translocation carriers may have only 10% to 30% normal embryos). In such cases, the doctor will discuss with the patient: whether to accept carrier embryos (applicable for some recessive genetic disorders), whether to consider egg or sperm donation, or whether to attempt another ovarian stimulation cycle.

VIII. Practitioner's Observation: Key Considerations for Choosing a PGT Hospital

As someone who has long been involved in editing reproductive medicine knowledge and patient education, I have observed that families with a history of genetic disorders often fall into several pitfalls when choosing a PGT hospital:

• Focusing only on reputation, not expertise. Some hospitals have a strong overall reputation, but their actual case accumulation for PGT-M or PGT-SR may be less than that of specialized hospitals. It is recommended to pay attention to the number of PGT cycles published by the hospital and the range of genetic disorders covered during initial screening.
• Neglecting the quality of genetic counseling. Half of PGT success lies in the laboratory, and the other half in genetic counseling. An excellent genetic counseling doctor can accurately determine whether a genetic disorder is suitable for PGT and design a precise testing protocol.
• Overemphasizing success rate numbers. The PGT success rates published by different hospitals vary greatly, but the population structures behind them differ. Younger patients with single-gene disorders naturally have higher success rates than older patients with chromosomal translocations. When comparing horizontally, look at data for similar patient groups.
• Underestimating the time commitment. From initial consultation to transfer, a PGT cycle typically takes 3 to 6 months. If family verification or multiple ovarian stimulation cycles are involved, it may take longer. Plan work and life arrangements accordingly.

My suggestion is: Get genetic counseling first, then choose a hospital. The genetic counseling doctor will provide clear testing requirements, and then match you with the most suitable reproductive center based on those needs. If possible, consult 2-3 centers, compare their protocols, and then make a decision.